DI LENARDA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 9.939
NA - Nord America 8.703
AS - Asia 4.053
SA - Sud America 553
Continente sconosciuto - Info sul continente non disponibili 485
AF - Africa 128
OC - Oceania 28
Totale 23.889
Nazione #
US - Stati Uniti d'America 8.508
RU - Federazione Russa 3.333
IT - Italia 2.838
PL - Polonia 1.538
SG - Singapore 1.469
CN - Cina 890
SE - Svezia 430
BR - Brasile 414
VN - Vietnam 400
DE - Germania 396
HK - Hong Kong 381
FR - Francia 246
UA - Ucraina 205
NL - Olanda 198
BD - Bangladesh 186
GB - Regno Unito 174
TR - Turchia 157
FI - Finlandia 152
KR - Corea 145
IN - India 104
BG - Bulgaria 92
CA - Canada 88
IE - Irlanda 85
JP - Giappone 75
ES - Italia 54
MX - Messico 46
AR - Argentina 42
BE - Belgio 37
MA - Marocco 36
CH - Svizzera 33
AU - Australia 27
ID - Indonesia 27
CO - Colombia 25
IQ - Iraq 24
PK - Pakistan 24
AT - Austria 21
TG - Togo 20
EC - Ecuador 19
IR - Iran 18
ZA - Sudafrica 18
KZ - Kazakistan 17
RO - Romania 17
TW - Taiwan 15
AE - Emirati Arabi Uniti 14
PE - Perù 14
PH - Filippine 14
CZ - Repubblica Ceca 13
PY - Paraguay 13
SA - Arabia Saudita 13
SN - Senegal 13
TH - Thailandia 13
VE - Venezuela 11
DK - Danimarca 10
JO - Giordania 10
MY - Malesia 10
PT - Portogallo 10
CR - Costa Rica 9
DZ - Algeria 9
KE - Kenya 9
CL - Cile 8
HN - Honduras 8
HR - Croazia 8
LT - Lituania 8
IL - Israele 7
HU - Ungheria 6
NI - Nicaragua 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
JM - Giamaica 5
KG - Kirghizistan 5
NO - Norvegia 5
NP - Nepal 5
PR - Porto Rico 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
EG - Egitto 4
EU - Europa 4
GT - Guatemala 4
LV - Lettonia 4
OM - Oman 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BS - Bahamas 2
BW - Botswana 2
CI - Costa d'Avorio 2
DM - Dominica 2
GG - Guernsey 2
GR - Grecia 2
MK - Macedonia 2
SI - Slovenia 2
Totale 23.376
Città #
Moscow 3.234
Warsaw 1.460
Ashburn 1.007
Singapore 916
Fairfield 739
Houston 654
Chandler 536
San Jose 515
Woodbridge 511
Hong Kong 369
Wilmington 353
Ann Arbor 346
Seattle 325
Cambridge 274
Milan 268
Trieste 235
Beijing 221
Jacksonville 220
Rome 206
Council Bluffs 167
Princeton 141
Seoul 141
Los Angeles 122
Boardman 119
Ho Chi Minh City 114
Chicago 110
Santa Clara 106
Hefei 101
Izmir 99
Columbus 91
Lauterbourg 86
Sofia 86
Dearborn 84
Dublin 82
New York 80
Hanoi 73
Helsinki 70
Frankfurt am Main 65
The Dalles 64
Zgierz 64
Munich 62
Naples 58
London 55
Turin 50
North Bergen 49
São Paulo 48
Buffalo 47
Dallas 47
Düsseldorf 44
Tokyo 43
San Diego 41
Bari 40
Bologna 40
Phoenix 37
Florence 34
Guangzhou 31
Brussels 30
Casablanca 29
Padova 29
Bremen 27
Denver 27
Grafing 27
Des Moines 26
Nuremberg 25
Palermo 25
Redondo Beach 25
Falls Church 24
Shanghai 24
Turku 24
Venice 24
Nanjing 23
Orem 23
Toronto 23
Atlanta 21
Genoa 21
Redwood City 21
Verona 21
Cagliari 20
Catania 20
Dong Ket 20
Kocaeli 20
Lomé 20
Montreal 20
Brescia 19
Brooklyn 19
Udine 19
Jinan 18
Pune 18
Chennai 17
Madrid 17
Stockholm 17
Amsterdam 16
Modena 16
Washington 16
Ankara 15
Bogotá 15
Boston 15
Haiphong 15
Norwalk 15
Tianjin 15
Totale 16.101
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. 3.353
Continuità assistenziale ospedale-territorio per il paziente con scompenso cardiaco cronico: Una rivoluzione e una sfida nella cura ambulatoriale 1.166
Documento di consenso ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: Il percorso clinico-diagnostico e terapeutico del paziente con scompenso cardiaco acuto dal domicilio alla dimissione dal Pronto Soccorso/ Dipartimento di Emergenza-Accettazione 892
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study 461
Should we fear direct oral anticoagulants more than vitamin K antagonists in simple single tooth extraction? A prospective comparative study 443
Natural History of Dilated Cardiomyopathy in Children 441
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 432
Role of Titin Missense Variants in Dilated Cardiomyopathy 428
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 419
Gingival overgrowth caused by Olmesartan Medoxomil: Observational study 403
Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography 380
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 371
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 370
Multi-state modelling of heart failure care path: A population-based investigation from Italy 363
La fibrillazione atriale non valvolare: dati dall’Osservatorio delle Malattie Cardiovascolari della provincia di Trieste [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)] 351
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 339
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 333
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 303
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up 301
Prognostic role of cardiac calcifications in primary prevention: A powerful marker of adverse outcome highly dependent on underlying cardiac rhythm 290
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 286
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 278
A new integrated approach to cardiac mechanics: reference values for normal left ventricle 276
Incremental Value of Gait Speed in Predicting Prognosis of Older Adults With Heart Failure. Insights From the IMAGE-HF Study 267
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 264
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 264
Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study 248
Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria. 245
Systolic blood pressure target in systemic arterial hypertension: Is lower ever better? Results from a community-based Caucasian cohort 244
Personalized support for chronic conditions. A novel approach for enhancing self-management and improving lifestyle. 238
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 237
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 233
Il raggiungimento dei target raccomandati di profilo lipidico in una popolazione con cardiopatia ischemica cronica: dalle linee guida al mondo reale 229
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 222
Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice: The "EPIDAURO registry" 222
Administrative database, observational research and the Tower of Babel 222
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Asymptomatic Aortic Stenosis 215
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 214
Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure 211
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: Data from the MECKI Score Research Group 206
Cardiomiopatie 2008. Una riflessione a proposito delle recenti classificazioni dell'American Heart Association e del Working Group on Myocardial and Pericardial Diseases della Società Europea di Cardiologia 204
HF progression among outpatients with HF in a community setting 203
Clinical implications of the CKD epidemiology collaboration (CKD-EPI) equation compared with the modification of diet in renal disease (MDRD) study equation for the estimation of renal dysfunction in patients with cardiovascular disease 201
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 199
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 198
Atrial fibrillation, cognitive impairment, frailty and disability in older heart failure patients 198
Insights from Cardiac Mechanics after Three Decades from Successfully Repaired Aortic Coarctation 196
Chronic kidney disease and prognosis in elderly patients with cardiovascular disease: Comparison between CKD-EPI and Berlin Initiative Study-1 formulas 194
Three dimensional printing of an atrial septal defect: Is it multimodality imaging? 194
Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy. 193
Uno sguardo allo scompenso cardiaco con frazione di eiezione preservata: dai trial al mondo reale dell’Osservatorio Cardiovascolare del Friuli-Venezia Giulia 192
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 192
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 187
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 187
Comparison of discrimination and calibration performance of ECG-based machine learning models for prediction of new-onset atrial fibrillation 180
Diagnosi e cura dell’amiloidosi cardiaca in Italia: risultati della survey della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 178
SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism. 178
Response to: “Direct oral anticoagulants, vitamin K antagonists and simple single tooth extraction” 177
Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. 176
Impact of left ventricular hemodynamic forces in adult patients with treated aortic coarctation and preserved left ventricular systolic function 175
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 175
Left ventricular function and exercise performance in idiopathic dilated cardiomyopathy: Role of tissue Doppler imaging 173
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 172
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. 166
[Disease management system in patients with chronic heart failure] 166
Managing heart failure in the very old 156
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 153
Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records 150
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction 148
Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease 147
Heart failure and anemia: Effects on prognostic variables 144
Wavelet‐Mixed Landmark Survival Models for the Effect of Short‐Term Changes of Potassium in Heart Failure Patients 139
The hemodynamic power of the heart differentiates normal from diseased right ventricles 138
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 134
Sex-related differences in chronic heart failure: a community-based study 132
Heart failure patients with improved ejection fraction: insights from the MECKI Score database 129
Impact of Atrial Fibrillation on Outcome of Patients with Idiopathic Dilated Cardiomyopathy: Data from the Heart Muscle Disease Registry of Trieste 125
Differences between MINOCA and type 2 myocardial infarction: An ITALIAN observational study 122
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population) 108
Is L-PRF an effective hemostatic agent in single tooth extractions? A cohort study on VKA and DOAC patients 104
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the MECKI score data-set 101
Tissue Doppler indices of diastolic function as prognosticator in patients without heart failure in primary care 95
Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors 91
LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience 85
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 72
Optimising Return to Work for Cardiovascular Patients: An Interdisciplinary Approach in Occupational Medicine and Cardiology 60
Management of Idiopathic Recurrent Pericarditis in Adults and in Children: A Role for IL-1 Receptor Antagonism 42
Totale 23.889
Categoria #
all - tutte 57.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.929


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.137 0 0 67 78 86 132 68 67 142 120 89 288
2022/20231.867 147 205 137 250 177 293 56 168 198 49 126 61
2023/20242.257 106 115 85 99 126 150 233 159 35 176 633 340
2024/20254.954 799 870 549 680 284 233 165 164 307 381 254 268
2025/20266.074 547 285 342 490 524 459 877 305 731 871 350 293
2026/2027760 235 320 205 0 0 0 0 0 0 0 0 0
Totale 23.889